 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CervoMed Announces Completion of Merger with EIP Pharma CervoMed Announces Completion of Merger with EIP Pharma PR Newswire BOSTON, Aug. 16, 2023 Shares of CervoMed to commence trading on Nasdaq...

CervoMed Announces Completion of Merger with EIP Pharma

CervoMed, Inc. is a clinical stage biotechnology company. It engages in the business of advancing CNS focused therapeutics to benefit patients with a range of degenerative diseases of the brain. The company is currently developing neflamapimod, an investigational orally administered small molecule brain penetrant that inhibits p38MAP kinase alpha. The company was founded in 2001 and is headquartered in Boston, MA.

Watchers	21,557
52-Wk Low	$4.14
52-Wk High	$14.37

Market Cap	$24.86M
Volume (M)	9,756.00
52-Wk High	$14.37
52-Wk Low	$4.14

CRVO CervoMed Inc

About

Feed

News

Sentiment

Fundamentals